Anticoagulant-related bleeding: clinical epidemiology, prediction, and prevention.
about
Warfarin reversalPersonalized versus non-personalized computerized decision support system to increase therapeutic quality control of oral anticoagulant therapy: an alternating time series analysisDrug interaction: omeprazole and phenprocoumonVenous and arterial thrombotic risks with thalidomide: evidence and practical guidanceOutcomes in the management of atrial fibrillation: clinical trial results can apply in practicePharmacoeconomics of anticoagulation therapy for stroke prevention in atrial fibrillation: a reviewThe risks of minor head injury in the warfarinised patient.Warfarin Pharmacogenetics: New Life for an Old DrugA New Pharmacogenetic Algorithm to Predict the Most Appropriate Dosage of Acenocoumarol for Stable Anticoagulation in a Mixed Spanish PopulationA role for pharmacists in community-based post-discharge warfarin management: protocol for the 'the role of community pharmacy in post hospital management of patients initiated on warfarin' study.Urgent reversal of warfarin with prothrombin complex concentrate: where are the evidence-based data?Clinical and genetic determinants of warfarin pharmacokinetics and pharmacodynamics during treatment initiationImplications of cytochrome P450 2C9 polymorphism on warfarin metabolism and dosing.Recombinant factor VIIa.Pitfalls in the Use of Anticoagulants.Contemporary use of and future roles for heparin in antithrombotic therapy.Meta-analysis of rare and adverse event data.Rapid genotyping of single nucleotide polymorphisms influencing warfarin drug response by surface-enhanced laser desorption and ionization time-of-flight (SELDI-TOF) mass spectrometry.Minor head trauma in anticoagulated patients.The role of angioplasty in acute myocardial infarction.Risk of post-discharge venous thromboembolism in patients with rheumatoid arthritis undergoing knee or hip arthroplasty. Is prolonged thromboprophylaxis warranted or dangerous?Gastrointestinal hemorrhage in warfarin anticoagulated patients: incidence, risk factor, management, and outcomeThe allele frequency of CYP2C9 and VKORC1 in the Southern Khorasan population.Warfarin therapy: in need of improvement after all these years.Fortnightly review: anticoagulation in heart disease.Pharmacogenetics of warfarin: challenges and opportunities.Comparison of warfarin therapy clinical outcomes following implementation of an automated mobile phone-based critical laboratory value text alert systemComparison of long versus short duration of anticoagulant therapy after a first episode of venous thromboembolism: a meta-analysis of randomized, controlled trials.A re-appraisal of warfarin control in the treatment of deep vein thrombosis and / or pulmonary embolism.Evaluation of warfarin initiation regimens in elderly inpatients.Etiology and management of coagulation abnormalities in the pain management patient.Use of warfarin in non-rheumatic atrial fibrillation: a commentary from general practice.Evaluation of computerized decision support for oral anticoagulation management based in primary care.Intracerebral haemorrhages and oral anticoagulation in the north of Scotland.Course, management and outcome of oral-anticoagulant-related intracranial haemorrhages.Long-term treatment with warfarin in Chinese population.Oral anticoagulation and risk of death: a medical record linkage study.The incidence of bleeding complications associated with warfarin treatment in general practice in the United Kingdom.Warfarin sensitivity related to CYP2C9, CYP3A5, ABCB1 (MDR1) and other factors.The management of coumarin-induced over-anticoagulation Annotation.
P2860
Q24672566-F993D60A-9ABC-4632-844E-5FEC41BE41C1Q24791904-FE07411D-548E-4086-8EE7-E764A09036A7Q24796927-C33D1FEA-3847-4F25-A9E2-5EDCFF9F9238Q27008491-7EADF613-5C5D-45E9-94AC-7F31283A2D4AQ28188553-95137B94-4688-4D18-92AF-FF3146285C93Q28218125-6491D972-1806-450D-8B1D-3EA001F6F54BQ28379585-A24204D7-C91A-4772-A67D-90AB313D0234Q28468726-9E480C2D-C1E8-4669-A79D-C71EB3FF9C8EQ28550740-3FE813B0-ECCC-44E2-BF4E-2BB4FE25226DQ30996878-65389698-BAD7-49C7-8828-3FCE69799693Q31040247-7522F7F0-B04F-4D83-A095-A364A2FBC923Q31042226-1BF5A62E-139C-4C55-99B1-AF20A301F965Q32049910-4F9B0ADC-3A6B-402C-A541-56881D5C46C6Q33363658-FF3D5AE0-ED61-4181-8029-10E6333A499BQ33441493-F351A90E-5B00-434C-8184-B02A6C03A355Q33495687-9CA19440-9998-401E-850B-9F9B4B7B5AD1Q33508895-D61BA656-CA90-46C4-B7C8-6A2BA66D3849Q33523960-A5F34704-251C-4266-8BE5-3F21AD5F3D37Q33537542-E627A38C-B56E-49E9-86AF-5E937891D829Q33568558-A11B387A-3251-4692-B90D-94E23468EA5DQ33669429-1233B9C9-2C91-4AD6-8CD6-F22C44F2EBABQ33760056-87C34478-FD88-48A8-A1F6-C963B1EA18B6Q33782314-A740BB1D-CCAE-4200-9FFD-4D53B7A3FB2AQ33793086-243CB109-1BD3-436D-A370-D87F267F0B94Q33793446-95DA96E0-71A4-40AE-B864-1F049673D2CFQ33819050-EB6AA764-3D61-438A-84C4-05F85E0BD46DQ33912263-F0F3B70E-AE26-4F61-AEE5-88FD0DA89677Q33917883-57C6B6F5-0680-4EDD-87BE-974EEBF58C95Q33918677-15D2EBA9-7B44-4D09-8E1B-AA4B100248BEQ34000986-BFAC9F89-B639-4F80-A923-4ADE6D05B8C3Q34040653-C66C6AAE-FA29-4688-99D3-1FDBE7540A47Q34053704-DFD77F4C-A436-4B87-944D-E50D5069CD73Q34055140-A9B392AA-5697-4F90-8108-CC9B51C7C661Q34075223-4682D2D6-3ACD-4994-9509-B03DC0BCF993Q34075227-F62DC8CA-9952-4B39-9C75-0474E90A4E3BQ34122505-120068C9-3ADE-4150-95BA-58725701DF3FQ34210279-1E8EB668-5422-4588-A429-5E8301042A1FQ34223484-950534C9-2951-4DB2-BCEA-A1814A6BC779Q34283903-49680C16-4A80-4254-85FF-EA122D00D457Q34351118-E051FD51-9306-4DD4-9CD5-0B588F0AC030
P2860
Anticoagulant-related bleeding: clinical epidemiology, prediction, and prevention.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年学术文章
@wuu
1993年学术文章
@zh-cn
1993年学术文章
@zh-hans
1993年学术文章
@zh-my
1993年学术文章
@zh-sg
1993年學術文章
@yue
1993年學術文章
@zh
1993年學術文章
@zh-hant
name
Anticoagulant-related bleeding: clinical epidemiology, prediction, and prevention.
@en
type
label
Anticoagulant-related bleeding: clinical epidemiology, prediction, and prevention.
@en
prefLabel
Anticoagulant-related bleeding: clinical epidemiology, prediction, and prevention.
@en
P1476
Anticoagulant-related bleeding: clinical epidemiology, prediction, and prevention.
@en
P2093
C S Landefeld
P304
P356
10.1016/0002-9343(93)90285-W
P407
P577
1993-09-01T00:00:00Z